Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 267-012-8 | CAS number: 67762-34-9 This substance is identified by SDA Substance Name: C8-C18 and C18 unsaturated alkyl carboxylic acid zinc salt and SDA Reporting Number: 01-006-09.
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
- Toxic effect type:
- dose-dependent
Effects on fertility
Link to relevant study records
- Endpoint:
- screening for reproductive / developmental toxicity
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 421 (Reproduction / Developmental Toxicity Screening Test)
- GLP compliance:
- yes (incl. QA statement)
- Limit test:
- yes
- Species:
- rat
- Strain:
- Sprague-Dawley
- Details on species / strain selection:
- 2.4.2. Reason for test system selection
The Sprague-Dawley rats are widely used in reproductive toxicity studies and a large amount of historical data have been accumulated, facilitating the interpretation and evaluation of the test results.
2.4.3. Quarantine and acclimation
Upon receipt, all animals were kept in quarantine and acclimatized for 21 days under the environment of the animal room of CentralBio Co., Ltd. During this period, all animals were observed daily and only selected healthy animals were used in the study.
2.4.4. Animal and cage identification
Animals were individually identified on the tail by permanent markers, red in the acclimation period, and blue in the test period. Offspring were numbered using blue markers (males) and red markers (females). Identification cards including information such as colors by dose groups,
study number and animal number were attached to each cage. A log sheet was attached to the entrance of the animal room to identify the study.
2.4.5. Group assignment
Following the quarantine-acclimation period, selected healthy animals were randomly grouped based on body weights. In the case of females, animals with irregular oestrus cycles for 14 days was excluded. The evenness for the average and standard deviation of body weights per group will be checked during the group assignment.
2.4.6. Remnant animals
The remnant animals were humanely killed using CO2 gas. - Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- Species and strain : NSam: Sprague-Dawley Rat
Microbiological grade : Specific Pathogen Free(SPF)
Breeder : Samtako Bio Korea (105, Seorang-ro, Osan-si, Gyeonggi-do, Republic of Korea)
Supplier : Young Bio Co., Ltd. (388, Dunchon-daero, Jungwon-gu, Seongnam-si, Gyeonggi-do, Republic of Korea)
Sex Male Female
Number at receipt 44 50
Number at first dose 40 40
Age(week) at receipt 7 7
Age(week) at first dose 10 10
Body weight range at dose 327.6~397.6 g 204.3~243.1 g - Route of administration:
- oral: gavage
- Vehicle:
- DMSO
- Details on exposure:
- 3.2.3. Dose volume
The dose volume is set as 5 mL/kg, and the dose volumes for each animal was calculated based on the most recently measured body weight.
3.2.4. Method
The test substance was orally administered once by gavage using a feeding needle(sonde).
3.3. Euthanasia
Animals that were in moribund conditions or judged to have severe pain were not observed. - Details on mating procedure:
- 3.4.6.1. Paring method
1:1 pairing was use. The paring period will be up to 14 days and animals confirmed to evidence of mating were separated immediately. Additional mating were conducted by remating of females with proven males of the same group in case pairing is unsuccessful during the 7 day mating period.
3.4.6.2. Confirmation of mating
Each morning the females were examined for the presence of sperm or a vaginal plug. Gestation day(GD) 0 will be defined as the observation day of mating evidence. - Analytical verification of doses or concentrations:
- no
- Duration of treatment / exposure:
- The duration of administration of the test substance was 35 days for males, and 41~54 days for females, including before mating, gestation period, and lactation period
- Frequency of treatment:
- The test substance was administered once a day. For females, if there was specific events such as parturition, the administration time was adjusted according to the decision of the study director.
- Details on study schedule:
- Clinical sign observation and body weight measurement for pups were performed up to 13 days after birth, and AGD was measured on the 4th day after birth.
- Dose / conc.:
- 0 mg/kg bw/day (nominal)
- Dose / conc.:
- 100 mg/kg bw/day (nominal)
- Dose / conc.:
- 300 mg/kg bw/day (nominal)
- Dose / conc.:
- 1 000 mg/kg bw/day (nominal)
- No. of animals per sex per dose:
- 10 per male, 10 per female
- Control animals:
- yes, concurrent vehicle
- Details on study design:
- 3.1.1. Study group
Group Dose (mg/kg/day) Dose volume (mL/kg/day) Sex Number of animals Animal number
G1 Vehicle 0 5 Male 10 1-10
Female 10 41-50
G2 Low dose 100 5 Male 10 11-20
Female 10 51-60
G3 Middle dose 300 5 Male 10 21-30
Female 10 61-70
G4 High dose 1,000 5 Male 10 31-40
Female 10 71-80
3.1.2. Selection of dose
As a result of a 14-Day Repeated-dose Oral Toxicity DRF study(Study No.: 21-0599DF, CentralBio Co., Ltd.) at doses of 250, 500 and 1,000 mg/kg/day, salivation was observed in both sexes at 1,000 mg/kg/day in clinical sign. In the hematological test, HGB was decreased in male at ≥500 mg/kg/day. In the clinical biochemistry test, TP was decreased in both sexes at 1,000 mg/kg/day, AST and CK were increased in both sexes at 1,000 mg/kg/day, and Na+ was decreased in female at at ≥250 mg/kg/day. Based on the above results, the high dose for this study was set at 1,000 mg/kg/day, and the middle and low doses were set at 300 and 100 mg/kg/day by applying about three-fold intervals. - Oestrous cyclicity (parental animals):
- Monitoring the regularity and duration of the oestrous cycle by vaginal smear during the pretreat and pre-mating period. In addition, a vaginal smear was performed prior to necropsy to determine the oestrous cycle phase.
- Sperm parameters (parental animals):
- Each morning the females were examined for the presence of sperm or a vaginal plug. Gestation day(GD) 0 will be defined as the observation day of mating evidence.
- Postmortem examinations (parental animals):
- Necropsy was performed on the 36th day after administration for males and on the 13th day after parturition for females. On the day of necropsy, all surviving animals were anesthetized with 2-4% isoflurane, and when anesthesia is confirmed, blood was collected from the abdominal aorta. Females with no evidence of copulation was necropsied 24 to 26 days after the last mating day. Females with delayed parturition was necropsied on 24 to 26 days after the observation day of mating evidence.
- Postmortem examinations (offspring):
- Anesthetize with 3-5% isoflurane, and when anesthesia was confirmed, blood was collected from the heart. Blood was drawn from two or more pups on PND 4 and pooled regardless of sex. At PND 13, blood was drawn from least two pups per sex.
- Statistics:
- The data of body weight, food and water consumption, hematological test, and clinical biochemistry test, and organ weights were analyzed using SPSS statistical program(IBM, Ver 25.) to compare the homogeneity of variance. The one-way ANOVA(in assumption of normality, p<0.05) was performed followed by Levene’s test for equality of variances. In accordance with the result of Levene’s test, Dunnett test(equal variance) or Dunnett T3(unequal variance) were conducted as a post-hoc test to confirm the significance. In post-hoc test, p<0.05 is considered as statistically significant. The oestrous cycle during the acclimation period was presented only in appendix without statistical analysis. For parameters with only one result per group, such as an index, only dose-dependent responses are determined without statistical analysis.
- Reproductive indices:
- Reproductive performance[SOP-RPT-004, 005]
Calculated the index below.
Male mating index (%) = (No. of males mated/No. of males paired)×100
Female mating index (%) = (No. of females mated/No. of females paired)×100
Male fertility index (%) = (No. of males siring a litter/No. of males paired)×100
Female fertility index (%) = (No. of females pregnant/No. of females paired)×100
Male fecundity index (%) = (No. of males siring a litter/No. of males mated)×100
Pregnancy index (%) = (No. of females pregnant/No. females mated)×100 - Clinical signs:
- effects observed, treatment-related
- Description (incidence and severity):
- Salivation was observed in all males at 1,000 mg/kg/day .
Salivation was observed in all females at 1,000 mg/kg/day on the pre-mating, gestation period
and lactation period.
In pre-mating and gestation period, soiled perineal region was observed in all females at 1,000
mg/kg/day.
Else, in pre-mating, abdominal distention was observed in 3 female at 0 mg/kg/day and observed
in 1 female at 100 mg/kg/day. The change was not considered to be test substance-related
because it was observed as a judgment error when confirmation of a vaginal plug. - Mortality:
- no mortality observed
- Body weight and weight changes:
- no effects observed
- Food consumption and compound intake (if feeding study):
- effects observed, non-treatment-related
- Description (incidence and severity):
- There were no test substance-related changes.
Food consumptions in male at 300 mg/kg/day on Day 14 was significantly increased(p<0.05).
Food consumptions in male at 1,000 mg/kg/day on Day 7 was significantly increased(p<0.05).
The change was not considered to be test substance-related because there was temporary
observed. - Water consumption and compound intake (if drinking water study):
- effects observed, non-treatment-related
- Description (incidence and severity):
- There were no test substance-related changes.
Water consumptions in male at all test substance on Day 28 were significantly increased(p<0.05)
and in male at 1,000 mg/kg/day on Day 34 was significantly increased(p<0.05).
The changes were not considered to be test substance-related because there was observed due to
low levels at vehicle control group or no dose-response relationship. - Organ weight findings including organ / body weight ratios:
- no effects observed
- Histopathological findings: non-neoplastic:
- effects observed, non-treatment-related
- Description (incidence and severity):
- There were no test substance-related changes.
Else, degeneration of testis and infiltrate of epididymis were observed at 0 mg/kg/day in males.
Degeneration of testis and cell debris of epididymis were observed at 1,000 mg/kg/day in males.
The changes were not considered to be test substance related-change because there was observed
in vehicle control group or to be background changes. - Reproductive function: oestrous cycle:
- no effects observed
- Reproductive performance:
- no effects observed
- Key result
- Dose descriptor:
- NOAEL
- Effect level:
- 1 000 mg/kg bw/day (nominal)
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- clinical signs
- mortality
- body weight and weight gain
- food consumption and compound intake
- water consumption and compound intake
- organ weights and organ / body weight ratios
- histopathology: non-neoplastic
- Clinical signs:
- effects observed, non-treatment-related
- Description (incidence and severity):
- There were no test substance-related changes.
In clinical signs and external examination, small was observed in each 1 and 2 males at 0 and
100 mg/kg/day. Small was observed in each 3, 4, 1 and 2 females at 0, 100, 300 and 1,000
mg/kg/day. Acaudate was observed in 1 female at 300 mg/kg/day. The changes were not
considered to be test substance-related because there was no dose-response relationship. - Mortality / viability:
- mortality observed, non-treatment-related
- Description (incidence and severity):
- In mortality, 4 dead pups(2 males and 2 females) was observed in vehicle control group, 3 dead
pups(2 males and 1 female) were observed at 100 mg/kg/day, and 1 dead pup(1 male) were
observed at 300 mg/kg/day, and 2 dead pups(2 males) observed at 1,000 mg/kg/day. - Body weight and weight changes:
- no effects observed
- Anogenital distance (AGD):
- no effects observed
- Nipple retention in male pups:
- no effects observed
- Key result
- Dose descriptor:
- NOAEL
- Generation:
- F1
- Effect level:
- 1 000 mg/kg bw/day (nominal)
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- clinical signs
- mortality
- body weight and weight gain
- Key result
- Reproductive effects observed:
- no
- Conclusions:
- The purpose of this study was to confirm the initial information of reproduction/developmental toxicity of the Fatty acids, C8-18 and C18-unsatd., zinc salts, following a repeated oral administration to Sprague-Dawley rats.
The test substance, Fatty acids, C8-18 and C18-unsatd., zinc salts was administered at a dose level of 100, 300, and 1,000 mg/kg/day to 10 males and 10 females per group and compared to the vehicle control group administered with DMSO. The duration of administration of the test substance was 35 days for males, and 41~54 days for females, including before mating, gestation period, and lactation period. Clinical sign observation and body weight measurement for pups were performed up to 13 days after birth, and AGD was measured on the 4th day after birth.
[Parents]
There were no test substance-related effects in clinical signs, body weights, food consumptions, water consumptions, estrus cycle, reproductive performance organ weights necropsy findings, hormone concentration and histopathological examination.
[Offspring]
There were no test substance-related effects in clinical signs, external examination, body weights, Pups index, anogenital index, number of nipples and areolas, necropsy findings, hormone concentration and histopathological examination.
Based on the above results, Fatty acids, C8-18 and C18-unsatd., zinc salts administered orally to Sprague-Dawley rats at 100, 300 and 1,000 mg/kg/day, the NOAEL of the Fatty acids, C8-18 and C18- unsatd., zinc salts was determined to be 1,000 mg/kg/day for males, pregnant females and offspring.
Reference
Effect on fertility: via oral route
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- NOAEL
- 1 000 mg/kg bw/day
- Study duration:
- subacute
- Experimental exposure time per week (hours/week):
- 168
- Species:
- rat
Justification for classification or non-classification
Additional information
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.